Showing results (171-180 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|December 21, 2011
Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine AMichel White, Augusto C Montezano, Rhian M TouyzTherapeutic Advances in Cardiovascular Disease|September 7, 2011
The effect of amlodipine besylate, losartan potassium, olmesartan medoxomil, and other antihypertensives on central aortic blood pressure and biomarkers of vascular functionBobby V KhanTherapeutic Advances in Cardiovascular Disease|September 7, 2011
The facts behind niacinWillibald Hochholzer, David D Berg, Robert P GiuglianoTherapeutic Advances in Cardiovascular Disease|December 31, 2016
Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendationsMichael S Kelly, Joseph J Saseen, Joel C MarrsTherapeutic Advances in Cardiovascular Disease|May 7, 2014
Aortic distensibility in bicuspid aortic valve patients with normal aortic diameterAlireza Moaref, Mohammad Khavanin, Shahnaz ShekarforoushTherapeutic Advances in Cardiovascular Disease|July 20, 2014
Adiponectin expression and the cardioprotective role of the vitamin D receptor activator paricalcitol and the angiotensin converting enzyme inhibitor enalapril in ApoE-deficient miceEdu Suarez-Martinez, Kazim Husain, Leon FerderTherapeutic Advances in Cardiovascular Disease|December 19, 2015
Edoxaban in patients with atrial fibrillationAlon Eisen, Christian T RuffTherapeutic Advances in Cardiovascular Disease|October 23, 2015
Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the ratClaudia Mera, Iván Godoy, Renato Ramírez, et al.Therapeutic Advances in Cardiovascular Disease|February 12, 2016
Potential role of systemic thrombolysis in acute submassive intermediate risk pulmonary embolism: review and future perspectivesMohamed Teleb, Mateo Porres-Aguilar, Javier E Anaya-Ayala, et al.Therapeutic Advances in Cardiovascular Disease|February 28, 2016
Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: a pharmacoepidemiologic perspectiveAnkit Sutaria, Longjian Liu, Ziauddin AhmedPageof 48